Iboga alkaloid congeners attenuate fentanyl seeking during prolonged abstinence after vapor self-administration

Keyphrases

• Abstinence 14%
• Abstinence Rate 14%
• Anti-addiction 14%
• Antidepressants 14%
• Anxiolytic Activity 14%
• C57BL 14%
• Catharanthine 71%
• Crossover Design 14%
• Cue-induced Drug Seeking 28%
• Drug Bioavailability 14%
• Drug Seeking 14%
• Fentanyl 100%
• Forced Abstinence 14%
• Home Cage 14%
• Iboga 14%
• Iboga Alkaloid 100%
• Ibogaine Analog 14%
• Inhalation 14%
• Novel Pharmacotherapy 14%
• Operant Chamber 14%
• Opioid Self-administration 14%
• Opioid Use Disorder 57%
• Overdose Deaths 28%
• Pharmaceutics 14%
• Prolonged Abstinence 100%
• Psychiatric Illness 14%
• Record-breaking 14%
• Self-administer 28%
• Self-administration 100%
• Self-administration Model 14%
• Tight 14%
• Vaping 14%
• Vapor Injection 28%
• μ-opioid Receptor 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Antidepressant 14%
• Bioavailability 14%
• C57BL 6 Mouse 14%
• Catharanthine 71%
• Disease 71%
• Drug Seeking Behavior 14%
• Duragesic 100%
• Ibogaine 100%
• N [2 (2 Methoxyphenyl)acetyl]dehydroalanine 28%
• Opiate 85%
• Pharmacotherapy 14%
• Prevalence 14%
• Toxic Injury 28%

Neuroscience

• Antidepressant 14%
• Catharanthine 71%
• Drug Seeking Behavior 14%
• Duragesic 100%
• Fentanyl 100%
• Iboga 100%
• Opiate 14%
• Opioid Abuse 57%
• Synthetic Opioids 14%